Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128939) titled 'Functional Study of Protein Modifications in the Tumorigenesis and Progression of Multiple Cancers' on July 28.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: The Second Hospital,University of South China

Condition: Cancer

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-08-01

Target Sample Size: Observation group:300;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=335021

Published by HT Digital Content Services with permission from Health Daily Digest....